Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 902137, 8 pages
Research Article

Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy

1The Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, 52621 Tel Hashomer, Israel
2Talpiot Medical Leadership Program, Sheba Medical Center, 52621 Tel Hashomer, Israel
3Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, 69102 Tel Aviv, Israel

Received 16 July 2015; Revised 8 October 2015; Accepted 15 October 2015

Academic Editor: Roberta Castriconi

Copyright © 2015 R. Ortenberg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • Matthew Dankner, Scott D Gray-Owen, Yu-Hwa Huang, Richard S Blumberg, and Nicole Beauchemin, “CEACAM1 as a Multi-Purpose Target for Cancer Immunotherapy,” OncoImmunology, pp. 00–00, 2017. View at Publisher · View at Google Scholar
  • Karin Kfir-Elirachman, Rona Ortenberg, Bella Vizel, Michal J Besser, Iris Barshack, Jacob Schachter, Yael Nemlich, and Gal Markel, “Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells,” Neoplasia, vol. 20, no. 4, pp. 401–409, 2018. View at Publisher · View at Google Scholar
  • Andreea Calinescu, Gabriela Turcu, Roxana I. Nedelcu, Alice Brinzea, Anastasia Hodorogea, Mihaela Antohe, Carmen Diaconu, Coralia Bleotu, Daniel Pirici, Lucia B. Jilaveanu, Daniela A. Ion, and Ioana A. Badarau, “On the Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) in Human Malignancies,” Journal of Immunology Research, vol. 2018, pp. 1–8, 2018. View at Publisher · View at Google Scholar
  • Ioannis A. Voutsadakis, “Immune ligands for cytotoxic T Lymphocytes (CTLS) in cancer stem cells (CSCS),” Frontiers in Bioscience - Landmark, vol. 23, no. 3, pp. 563–583, 2018. View at Publisher · View at Google Scholar